This gene is a member of the cadherin superfamily, genes encoding calcium-dependent, membrane-associated glycoproteins. The encoded protein is cadherin-like, consisting of an extracellular region, containing 7 cadherin domains, and a transmembrane region but lacking the conserved cytoplasmic domain. The protein is a component of the gastrointestinal tract and pancreatic ducts, acting as an intestinal proton-dependent peptide transporter in the first step in oral absorption of many medically important peptide-based drugs. The protein may also play a role in the morphological organization of liver and intestine. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2009].
Solcia, Klersy, Vanoli, Grillo, Manca, Tava, Luinetti, Fiocca: "The contribution of cell phenotype to the behavior of gastric cancer." in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, Vol. 16, Issue 4, pp. 462-71, (2013) (PubMed).
Park, Seol, Choi, Roh, Choi, Lee, Roh et al.: "Comparison of cadherin-17 expression between primary colorectal adenocarcinomas and their corresponding metastases: the possibility of a diagnostic marker for detecting the primary site of metastatic ..." in: Histopathology, Vol. 58, Issue 2, pp. 315-8, (2011) (PubMed).
Magnusson, de Wit, Brennan, Johnson, McGee, Lundberg, Naicker, Klinger, Kampf, Asplund, Wester, Gry, Bjartell, Gallagher, Rexhepaj, Kilpinen, Kallioniemi, Belt, Goos, Meijer, Birgisson, Glimelius et al.: "SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. ..." in: The American journal of surgical pathology, Vol. 35, Issue 7, pp. 937-48, (2011) (PubMed).
Su, Yuan, Lin, Jeng: "Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system." in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 21, Issue 11, pp. 1379-86, (2008) (PubMed).